Publications
Arabinose-induction of lac-derived promoter systems for penicillin acylase production in Escherichia coli. Biotechnology Progress, 22, 617-625.
. (2006). High-level gene expression for recombinant penicillin acylase production using the araB promoter system in Escherichia coli. Biotechnology Progress, 22, 1518-1523.
. (2006). Effect of heat-shock proteins for relieving physiological stress and enhancing the production of penicillin acylase in Escherichia coli. Biotechnology and Bioengineering, 96, 956-966. 2006_effect_of_heat-shock_proteins_for_relieving_physiological_stress_and_enhancing_the_production_of_penicillin_acylase_in_escherichia_coli.pdf
. (2007). Engineering cell physiology to enhance recombinant protein production in Escherichia coli. Applied Microbiology and Biotechnology, 76, 521-532. 2007_engineering_cell_physiology_to_enhance_recombinant_protein_production_in_escherichia_coli.pdf
. (2007). Preparation of inorganic-organic anion-exchange membranes and their application in plasmid DNA and RNA separation. Journal of Membrane Science, 311, 336-348.
. (2008). . (2008). Enhancing functional expression of heterologous lipase in the periplasm of Escherichia coli. World Journal of Microbiology & Biotechnology, 24, 2827-2835.
. (2008). Heterologous expression of lipase in Escherichia coli is limited by folding and disulfide bond formation. Applied Microbiology and Biotechnology, 81, 79-87.
. (2008). Effect of folding factors in rescuing unstable heterologous lipase B to enhance its overexpression in the periplasm of Escherichia coli. Applied Microbiology and Biotechnology, 79, 1035-1044.
. (2008). In vivo monitoring and alleviation of extracytoplasmic stress to recombinant protein overproduction in the periplasm of Escherichia coli. Biochemical Engineering Journal, 42, 13-19.
. (2008). Periplasmic chaperone FkpA reduces extracytoplasmic stress response and improves cell-surface display on Escherichia coli. Enzyme and Microbial Technology, 42, 506-513.
. (2008). Physiological improvement to enhance Escherichia coli cell-surface display via reducing extracytoplasmic stress. Biotechnology Progress, 24, 293-301.
. (2008). Bioprocess development for production, purification, and structural characterization of recombinant hCD83ext as a potential therapeutic protein. Protein Expression and Purification, 65, 92-99.
. (2009). Alleviation of Proteolytic Sensitivity To Enhance Recombinant Lipase Production in Escherichia coli. Applied and Environmental Microbiology, 75, 5424-5427. 2009_alleviation_of_proteolytic_sensitivity_to_enhance_recombinant_lipase_production_in_escherichia_coli.pdf
. (2009). Metabolic pathways of clostridia for producing butanol. Biotechnology Advances, 27, 764-781. 2009_metabolic_pathways_of_clostridia_for_producing_butanol.pdf
. (2009). Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection. Transplantation, 90, 1145-1156.
(2010). Strain improvement of Escherichia coli to enhance recombinant protein production. In Manual of Industrial Microbiology and Biotechnology (3rd ed., pp. 273-286). ASM Press. asm_mimb3_ch19.pdf
. (2010). Effect of aberrant disulfide bond formation on protein conformation and molecular property of recombinant therapeutics. Pure and Applied Chemistry, 82, 149-159.
. (2010). Structural identification of recombinant human CD83 mutant variant as a potent therapeutic protein. Protein Expression and Purification, 73, 140-146.
(2010). Enhancing functional expression of heterologous lipase B in Escherichia coli by extracellular secretion. Journal of Industrial Microbiology & Biotechnology, 37, 349-361.
. (2010).